{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:57:14Z","timestamp":1770469034497,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11739-024-03564-0","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T19:02:19Z","timestamp":1709060539000},"page":"1177-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The warfarin renaissance"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"8631","key":"3564_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0140-6736(89)91200-2","volume":"1","author":"P Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1(8631):175\u2013179. https:\/\/doi.org\/10.1016\/s0140-6736(89)91200-2","journal-title":"Lancet"},{"issue":"14 Suppl","key":"3564_CR2","first-page":"S462","volume":"10","author":"Albers GW; SPORTIF Investigators","year":"2004","unstructured":"Albers GW; SPORTIF Investigators (2004) Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Am J Manag Care 10(14 Suppl):S462\u2013S469","journal-title":"Am J Manag Care"},{"key":"3564_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1538-7836.2005.01184.x","volume":"3","author":"V Pengo","year":"2005","unstructured":"Pengo V (2005) Antithrombotic strategies for atrial fibrillation: on the threshold of changes? No J Thromb Haemost 3:433\u2013435","journal-title":"No J Thromb Haemost"},{"issue":"13","key":"3564_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","volume":"369","author":"JW Eikelboom","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M et al (2013) Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 369(13):1206\u20131214. https:\/\/doi.org\/10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"issue":"3","key":"3564_CR5","first-page":"324","volume":"8","author":"MK Dewanjee","year":"1999","unstructured":"Dewanjee MK, Gross DR, Zhai P, Lanzo S, Shim H, Park K, Schaeffer DJ, Twardock AR (1999) Thrombogenicity of polyethylene oxide-bonded Dacron sewing ring in a mechanical heart valve. J Heart Valve Dis 8(3):324\u2013330 (PMID: 10399669)","journal-title":"J Heart Valve Dis"},{"issue":"13","key":"3564_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","volume":"132","author":"V Pengo","year":"2018","unstructured":"Pengo V, Denas G, Zoppellaro G et al (2018) Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 132(13):1365\u20131371. https:\/\/doi.org\/10.1182\/blood-2018-04-848333","journal-title":"Blood"},{"issue":"10","key":"3564_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/M19-0291","volume":"171","author":"J Ordi-Ros","year":"2019","unstructured":"Ordi-Ros J, S\u00e1ez-Comet L, P\u00e9rez-Conesa M et al (2019) Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial. Ann Intern Med 171(10):685\u2013694. https:\/\/doi.org\/10.7326\/M19-0291","journal-title":"Ann Intern Med"},{"issue":"1","key":"3564_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","volume":"81","author":"CD Khairani","year":"2023","unstructured":"Khairani CD, Bejjani A, Piazza G et al (2023) Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol 81(1):16\u201330. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.008","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3564_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJMoa2209051","volume":"387","author":"SJ Connolly","year":"2022","unstructured":"Connolly SJ, Karthikeyan G, Ntsekhe M et al (2022) Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med 387(11):978\u2013988. https:\/\/doi.org\/10.1056\/NEJMoa2209051","journal-title":"N Engl J Med"},{"key":"3564_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300067","author":"TY Wang","year":"2023","unstructured":"Wang TY, Svensson LG, Wen J, Vekstein A, Gerdisch M, Rao VU et al (2023) Apixaban or warfarin in patients with an On-X mechanical aortic valve. N Engl J Med Evid. https:\/\/doi.org\/10.1056\/EVIDoa2300067","journal-title":"N Engl J Med Evid"},{"key":"3564_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.066485","author":"LPT Joosten","year":"2023","unstructured":"Joosten LPT, van Doorn S, van de Ven PM et al (2023) Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066485","journal-title":"Circulation"},{"issue":"FI1","key":"3564_CR12","doi-asserted-by":"publisher","first-page":"f20","DOI":"10.1093\/ehjcvp\/pvz073","volume":"7","author":"A Silverio","year":"2021","unstructured":"Silverio A, Di Maio M, Prota C et al (2021) Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients. Eur Heart J Cardiovasc Pharmacother 7(FI1):f20\u2013f29","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03564-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:15:30Z","timestamp":1718824530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03564-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3564"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03564-0","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and Informed consent"}}]}}